PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20655210-0	2010	X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors.	1,3-Diphenylguanidine	116-119	mitogen-activated protein kinase 9	Homo sapiens	27-31	
20655210-3	2010	This shows for the first time a JNK subfamily member in the DFG-out conformation.	1,3-Diphenylguanidine	60-63	mitogen-activated protein kinase 9	Homo sapiens	32-35	
20655210-6	2010	For the design of selective DFG-out binding JNK2 inhibitors, the binding pocket of the BIRB796 tolyl group may have the best potential.	1,3-Diphenylguanidine	28-31	mitogen-activated protein kinase 9	Homo sapiens	44-48	
35224496-5	2022	Additionally, the simulations prospectively predicted several druggable cysteine and lysine sites, including the alphaH head cysteine in JNK1/3 and DFG + 6 cysteine in JNK2, corroborating the chemical proteomic screening data.	1,3-Diphenylguanidine	148-151	mitogen-activated protein kinase 9	Homo sapiens	168-172